Study on Carboplatin and 5-Fluorouracil with Radiation for Lung Cancer
Author Information
Author(s): Yoshizawa H, Tanaka J, Kagamu H, Maruyama Y, Miyao H, Ito K, Sato T, Iwashima A, Suzuki E, Gejyo F
Primary Institution: Niigata University Graduate School of Medical and Dental Sciences
Hypothesis
Can a combination of daily carboplatin and 5-fluorouracil with concurrent radiation therapy improve outcomes for patients with locally advanced non-small-cell lung cancer?
Conclusion
The combination of daily carboplatin and 5-FU with concurrent radiation therapy was found to be effective and feasible for treating locally advanced non-small-cell lung cancer.
Supporting Evidence
- The study included 46 patients with locally advanced non-small-cell lung cancer.
- The overall response rate was 76.7%, with 70% achieving a partial response.
- Local control was achieved in 85.7% of patients.
Takeaway
Doctors tested a new treatment for lung cancer that combines two medicines with radiation, and it helped many patients feel better.
Methodology
Patients received daily carboplatin and continuous infusion of 5-FU along with radiation therapy, and their responses were evaluated.
Limitations
The study focused on local control but did not address distant metastasis effectively.
Participant Demographics
{"total_patients":46,"male":42,"female":4,"median_age":59.5,"stage_IIIA":26,"stage_IIIB":20}
Statistical Information
Confidence Interval
95% CI, 62–92%
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website